SI2292231T1 - Terapevtsko sredstvo za stenozo spinalnega kanala - Google Patents
Terapevtsko sredstvo za stenozo spinalnega kanalaInfo
- Publication number
- SI2292231T1 SI2292231T1 SI200931341T SI200931341T SI2292231T1 SI 2292231 T1 SI2292231 T1 SI 2292231T1 SI 200931341 T SI200931341 T SI 200931341T SI 200931341 T SI200931341 T SI 200931341T SI 2292231 T1 SI2292231 T1 SI 2292231T1
- Authority
- SI
- Slovenia
- Prior art keywords
- therapeutic agent
- spinal canal
- canal stenosis
- stenosis
- spinal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008162638 | 2008-06-23 | ||
| PCT/JP2009/061285 WO2009157396A1 (ja) | 2008-06-23 | 2009-06-22 | 脊柱管狭窄症治療剤 |
| EP09770106.4A EP2292231B1 (en) | 2008-06-23 | 2009-06-22 | Therapeutic agent for spinal canal stenosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2292231T1 true SI2292231T1 (sl) | 2016-03-31 |
Family
ID=41444462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200931341T SI2292231T1 (sl) | 2008-06-23 | 2009-06-22 | Terapevtsko sredstvo za stenozo spinalnega kanala |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8629145B2 (sl) |
| EP (1) | EP2292231B1 (sl) |
| JP (1) | JP5527205B2 (sl) |
| KR (1) | KR101626168B1 (sl) |
| CN (3) | CN102065863A (sl) |
| CA (1) | CA2728089C (sl) |
| CY (1) | CY1117080T1 (sl) |
| DK (1) | DK2292231T3 (sl) |
| ES (1) | ES2557303T3 (sl) |
| HR (1) | HRP20151443T1 (sl) |
| HU (1) | HUE025885T2 (sl) |
| PL (1) | PL2292231T3 (sl) |
| PT (1) | PT2292231E (sl) |
| SI (1) | SI2292231T1 (sl) |
| WO (1) | WO2009157396A1 (sl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104761509A (zh) * | 2008-02-28 | 2015-07-08 | 日本新药株式会社 | 纤维化抑制剂 |
| PT2447254T (pt) | 2009-06-26 | 2018-01-04 | Nippon Shinyaku Co Ltd | Cristais |
| WO2011024874A1 (ja) * | 2009-08-26 | 2011-03-03 | 日本新薬株式会社 | 塩基付加塩 |
| IL310203A (en) | 2015-12-02 | 2024-03-01 | Nippon Shinyaku Co Ltd | Pharmaceutical preparation containing 2-{4-[N-(6,5-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide |
| CN109563055B (zh) * | 2016-07-29 | 2021-12-24 | 成都苑东生物制药股份有限公司 | 氨基吡嗪类化合物或盐、异构体、其制备方法及用途 |
| JOP20190204A1 (ar) | 2017-03-08 | 2019-09-05 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على سيليكسيباغ |
| AR112842A1 (es) | 2017-09-28 | 2019-12-18 | Nippon Shinyaku Co Ltd | Cristal de pirazina |
| US10407396B2 (en) * | 2017-11-16 | 2019-09-10 | Apotex Inc. | Crystalline form of selexipag |
| MX2020004962A (es) | 2017-11-16 | 2020-08-27 | Nippon Shinyaku Co Ltd | Preparacion de liberacion controlada. |
| IL292354A (en) | 2019-10-23 | 2022-06-01 | Actelion Pharmaceuticals Ltd | A pharmaceutical preparation containing Selexifag |
| JP2023512273A (ja) | 2020-01-31 | 2023-03-24 | アクテリオン ファーマシューティカルズ リミテッド | 制御放出セレキシパグ組成物 |
| TW202239408A (zh) | 2021-01-29 | 2022-10-16 | 瑞士商艾克泰聯製藥有限公司 | 包含二苯基吡𠯤衍生物的醫藥組成物 |
| TW202241425A (zh) | 2021-01-29 | 2022-11-01 | 瑞士商艾克泰聯製藥有限公司 | 用於製造二苯基吡𠯤衍生物之程序 |
| EP4316489A1 (en) * | 2021-03-31 | 2024-02-07 | Nippon Shinyaku Co., Ltd. | Therapeutic agent for gait disturbance |
| JP7010404B1 (ja) | 2021-03-31 | 2022-02-10 | 日本新薬株式会社 | 歩行障害治療剤 |
| WO2023131608A1 (en) | 2022-01-04 | 2023-07-13 | Actelion Pharmaceuticals Ltd | Controlled release compositions |
| WO2023214059A1 (en) | 2022-05-06 | 2023-11-09 | Actelion Pharmaceuticals Ltd | Diphenylpyrazine compounds as prodrugs |
| WO2024017964A1 (en) | 2022-07-20 | 2024-01-25 | Actelion Pharmaceuticals Ltd | Injectable pharmaceutical composition comprising a diphenylpyrazine derivative |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI316055B (sl) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| BR0307780A (pt) * | 2002-02-19 | 2004-12-28 | Ono Pharmaceutical Co | Compostos derivados de piridazina fundida e medicamentos contendo os compostos como o ingrediente ativo |
| JP4497320B2 (ja) | 2002-10-10 | 2010-07-07 | 小野薬品工業株式会社 | 内因性修復因子産生促進剤 |
| CN104761509A (zh) * | 2008-02-28 | 2015-07-08 | 日本新药株式会社 | 纤维化抑制剂 |
-
2009
- 2009-06-22 PT PT97701064T patent/PT2292231E/pt unknown
- 2009-06-22 EP EP09770106.4A patent/EP2292231B1/en active Active
- 2009-06-22 DK DK09770106.4T patent/DK2292231T3/en active
- 2009-06-22 CN CN2009801246839A patent/CN102065863A/zh active Pending
- 2009-06-22 HU HUE09770106A patent/HUE025885T2/en unknown
- 2009-06-22 PL PL09770106T patent/PL2292231T3/pl unknown
- 2009-06-22 CN CN201310697705.9A patent/CN103690541A/zh active Pending
- 2009-06-22 ES ES09770106.4T patent/ES2557303T3/es active Active
- 2009-06-22 JP JP2010517991A patent/JP5527205B2/ja active Active
- 2009-06-22 WO PCT/JP2009/061285 patent/WO2009157396A1/ja active Application Filing
- 2009-06-22 CA CA2728089A patent/CA2728089C/en active Active
- 2009-06-22 KR KR1020107027945A patent/KR101626168B1/ko active IP Right Grant
- 2009-06-22 US US13/000,758 patent/US8629145B2/en active Active
- 2009-06-22 CN CN201510331290.2A patent/CN105168218A/zh active Pending
- 2009-06-22 SI SI200931341T patent/SI2292231T1/sl unknown
-
2015
- 2015-12-29 CY CY20151101199T patent/CY1117080T1/el unknown
- 2015-12-31 HR HRP20151443TT patent/HRP20151443T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2292231B1 (en) | 2015-10-21 |
| CA2728089C (en) | 2017-04-11 |
| CA2728089A1 (en) | 2009-12-30 |
| PL2292231T3 (pl) | 2016-03-31 |
| EP2292231A4 (en) | 2012-03-28 |
| CN105168218A (zh) | 2015-12-23 |
| ES2557303T3 (es) | 2016-01-25 |
| CN102065863A (zh) | 2011-05-18 |
| KR20110033125A (ko) | 2011-03-30 |
| DK2292231T3 (en) | 2015-12-14 |
| JP5527205B2 (ja) | 2014-06-18 |
| WO2009157396A1 (ja) | 2009-12-30 |
| JPWO2009157396A1 (ja) | 2011-12-15 |
| US8629145B2 (en) | 2014-01-14 |
| CY1117080T1 (el) | 2017-04-05 |
| KR101626168B1 (ko) | 2016-05-31 |
| HRP20151443T1 (hr) | 2016-01-29 |
| US20110105518A1 (en) | 2011-05-05 |
| EP2292231A1 (en) | 2011-03-09 |
| CN103690541A (zh) | 2014-04-02 |
| HUE025885T2 (en) | 2016-05-30 |
| PT2292231E (pt) | 2015-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2292231A4 (en) | THERAPEUTIC AGENT FOR SPINAL CANAL STENOSIS | |
| HK1223262A1 (zh) | 醫療器械 | |
| HK1206651A1 (en) | Implant for tissue engineering | |
| HK1205005A1 (en) | Bone treatment systems | |
| EP2308493A4 (en) | ENHANCING OR THERAPEUTIC AGENT FOR DYSLIPIDEMIA | |
| HK1137158A1 (en) | Formulations for cancer treatment | |
| HK1168749A1 (en) | Medical apparatus | |
| ZA201000013B (en) | Medical implant | |
| EP2189100A4 (en) | MEDICAL DEVICE | |
| ZA201001417B (en) | Medical implant | |
| GB0719608D0 (en) | Medical Apparatus | |
| EP2338457A4 (en) | MEDICAL BED | |
| EP2341852A4 (en) | ORTHOPEDIC IMPLANT | |
| EP2078536A4 (en) | MEDICAL DEVICE | |
| EP2127671A4 (en) | THERAPEUTIC AGENT AGAINST CANCER | |
| ZA200907492B (en) | Compositions for targeted imaging and therapy | |
| ZA201100697B (en) | Orthopedic prosthesis | |
| IL209006A0 (en) | Therapeutic agent for male sterility | |
| IL208664A0 (en) | Conjugates for the treatment of mesothelioma | |
| EP2236148A4 (en) | MEDIinic agent for HELICOBACTER treatment | |
| EP2140876A4 (en) | THERAPEUTIC AGENT COMPRISING VASOHIBINE | |
| GB0704334D0 (en) | Patient bed | |
| EP2127658A4 (en) | THERAPEUTIC AGENT AGAINST MORBUS MENIERE | |
| EP2210878A4 (en) | THERAPEUTIC AGENT AGAINST TRPV1-MEDIATED DISEASES | |
| GB0812940D0 (en) | Medical implant |